What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships

What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships

Submitted by admin on November 16, 2019 - 10:35pm
Source: 
Biopharma Dive
News Tags: 
Amarin
Vascepa
John Thero
labeling
Headline: 
What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships
snippet: 

Amarin will consider adding a partner in Europe, CEO John Thero told BioPharma Dive, adding he views the heart drug as a volume, not pricing, opportunity.

Do Not Allow Advertisers to Use My Personal information